Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-03-07

Clinical Trial Update: A Study of PRCL-02 in Healthy Volunteers and Plaque Psoriasis [Phase 1]

View source ↗

Summary

Phase 1 trial of PRCL-02 in healthy volunteers and individuals with plaque psoriasis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRCL-02

Snippet

Sponsor: PRCL Research Inc. | Conditions: Psoriasis | Phase 1 | Status: COMPLETED